4.5 Article

Optimization of 1,2,5-Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors

期刊

CHEMMEDCHEM
卷 10, 期 2, 页码 253-265

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201402453

关键词

ABHD6; 2-arachidonoylglycerol; cannabinoids; homology modeling; receptors; 1,2,5-thiadiazole carbamates

资金

  1. Graduate School of Drug Design, University of East Finland
  2. Academy of Finland [139140, 127653, 139620]
  3. Drug Discovery and Chemical Biology (DDCB) Consortium
  4. Biocenter Finland
  5. US National Institutes of Health (NIH) [R37-DK27083]
  6. Marie Curie Intra-European Fellowship
  7. Interdisciplinary Center for Mathematical and Computational Modeling (ICM), Warsaw, Poland [G30-18]
  8. Academy of Finland (AKA) [127653, 127653] Funding Source: Academy of Finland (AKA)

向作者/读者索取更多资源

At present, inhibitors of alpha/beta-hydrolase domain 6 (ABHD6) are viewed as a promising approach to treat inflammation and metabolic disorders. This article describes the development of 1,2,5-thiadiazole carbamates as ABHD6 inhibitors. Altogether, 34 compounds were synthesized, and their inhibitory activity was tested using lysates of HEK293 cells transiently expressing human ABHD6 (hABHD6). Among the compound series, 4-morpholino-1,2,5-thiadiazol-3-yl cyclooctyl(methyl) carbamate (JZP-430) potently and irreversibly inhibited hABHD6 (IC50 = 44 nm) and showed similar to 230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL), the main off-targets of related compounds. Additionally, activity-based protein profiling indicated that JZP-430 displays good selectivity among the serine hydrolases of the mouse brain membrane proteome. JZP-430 has been identified as a highly selective, irreversible inhibitor of hABHD6, which may provide a novel approach in the treatment of obesity and type II diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus

Rosa Sparaco, Ewa Kedzierska, Agnieszka A. Kaczor, Anna Bielenica, Elisa Magli, Beatrice Severino, Angela Corvino, Ewa Gibula-Tarlowska, Jolanta H. Kotlinska, Giorgia Andreozzi, Paolo Luciano, Elisa Perissutti, Francesco Frecentese, Marcello Casertano, Anna Lesniak, Magdalena Bujalska-Zadrozny, Malgorzata Ozieblo, Raffaele Capasso, Vincenzo Santagada, Giuseppe Caliendo, Ferdinando Fiorino

Summary: A series of new derivatives were prepared and evaluated to identify selective ligands for serotonin receptors. The most active compounds, Norbo-4 and Norbo-18, showed high specificity and affinity towards the receptors.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery

Agata Zieba, Dariusz Matosiuk, Agnieszka A. A. Kaczor

Summary: Complex disorders like depression are still a puzzle for scientists. Genetic factors are important for predicting vulnerability, but it is difficult to estimate the risk for depression based on just one category of vulnerability criteria. Genetic factors also influence drug metabolism and can lead to increased drug resistance. Understanding the genetic basis of depression is crucial for developing new medications and effective management strategies. This review analyzes recent literature on the correlation between specific genes and depression, highlights high drug resistance in patients with major depressive disorder, and discusses future directions for drug discovery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α/β-Hydrolase Domain 6 (ABHD6)

Karine Mardon, Jayendra Z. Patel, Juha R. Savinainen, Damion H. R. Stimson, Caitlin R. M. Oyagawa, Natasha L. Grimsey, Mary-anne Migotto, Grace F. M. Njiru, Brett R. Hamilton, Gary Cowin, Jari Yli-Kauhaluoma, Wim Vanduffel, Idriss Blakey, Rajiv Bhalla, Christopher Cawthorne, Sofie Celen, Guy Bormans, Kristofer J. Thurecht, Muneer Ahamed

Summary: Multimodal imaging, through PET and MALDI imaging, is used to discover and validate a new probe targeting the ABHD6 enzyme. The PET ligand [18F]JZP-MA-11 is reported to have specific uptake in ABHD6-rich tissues and major brain regions, with brain uptake confirmed in a nonhuman primate study. In vivo pharmacological response upon ABHD6 inhibition is observed using MALDI imaging. These synergistic imaging efforts hold promise for improving our understanding of ABHD6-mediated endocannabinoid metabolism in peripheral and central nervous system disorders.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Synthesis, Structural and Behavioral Studies of Indole Derivatives D2AAK5, D2AAK6 and D2AAK7 as Serotonin 5-HT1A and 5-HT2A Receptor Ligands

Agnieszka A. Kaczor, Ewa Kedzierska, Tomasz M. Wrobel, Angelika Grudzinska, Angelika Pawlak, Tuomo Laitinen, Agata Bartyzel

Summary: Serotonin receptors regulate various physiological functions and behaviors, and three indole derivatives (D2AAK5, D2AAK6, and D2AAK7) were synthesized and studied as ligands for serotonin 5-HT1A and 5-HT2A receptors. X-ray studies revealed the crystal structure of D2AAK5, and the main interaction between the ligands and receptors was identified as a salt bridge. Molecular dynamic simulations confirmed the stability of the complexes, except for D2AAK7 in the 5-HT1A receptor. D2AAK7 showed anxiolytic activity, while D2AAK5 had a beneficial effect on memory processes.

MOLECULES (2023)

Review Biochemistry & Molecular Biology

Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis

Agnieszka A. Kaczor, Tomasz M. Wrobel, Damian Bartuzi

Summary: Allosteric modulation of G protein-coupled receptors (GPCRs) is a popular topic in medicinal chemistry nowadays. Allosteric modulators, compounds that bind to a receptor site different from the orthosteric sites, have several advantages. They are more selective, safer, and exhibit a ceiling effect. Allosteric modulators targeting dopamine D-2 receptor show potential as drugs for psychiatric and neurological diseases. This review provides an in-depth summary of current research on D-2 receptor modulators, including pharmacology, ligand-receptor interactions, and synthesis.

MOLECULES (2023)

Review Pharmacology & Pharmacy

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

Elena Puris, Gert Fricker, Mikko Gynther

Summary: Transporter-mediated drug resistance is a major obstacle in anticancer drug delivery. Low expression of SLC transporters in cancer cells limits drug uptake, resulting in drug therapy failure. Strategies targeting SLC transporters, such as prodrugs and nanocarriers, as well as modulation of transporter expression, hold promise for efficient drug delivery in cancer cells.

PHARMACEUTICS (2023)

Article Food Science & Technology

Food-Grade Bacteria Combat Pathogens by Blocking AHL-Mediated Quorum Sensing and Biofilm Formation

Kirsi Savijoki, Paola San-Martin-Galindo, Katriina Pitkaenen, Minnamari Edelmann, Annika Sillanpaeae, Cim van der Velde, Ilkka Miettinen, Jayendra Z. Patel, Jari Yli-Kauhaluoma, Mataleena Parikka, Adyary Fallarero, Pekka Varmanen

Summary: By studying the effects of metabolic end-products of food-associated lactobacilli and propionibacteria on biofilm formation of Gram-negative pathogenic bacteria, it was found that these end-products can disrupt the quorum sensing system of the pathogenic bacteria, leading to the inhibition of biofilm formation.
Article Radiology, Nuclear Medicine & Medical Imaging

18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use

Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose

Summary: Molecular imaging of somatostatin receptors is crucial in the clinical management of neuroendocrine tumors. PET imaging with 68Ga or 64Cu labeled somatostatin analogs is currently the gold standard, but practical and economic issues hinder widespread implementation of 68Ga imaging. Recent advancements in radiochemistry have enabled the use of 18F labeling, leading to promising clinical translations of 18F-labeled somatostatin analogs. This review presents updated clinical data and justifies the clinical application of these tracers.

JOURNAL OF NUCLEAR MEDICINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist

Stephen Ahenkorah, Christopher Cawthorne, Erika Murce, Christophe M. Deroose, Thomas Cardinaels, Yann Seimbille, Guy Bormans, Maarten Ooms, Frederik Cleeren

Summary: In this study, [18F]AlF-NOTA-JR11 was synthesized and directly compared with [18F]AlF-NOTA-octreotide as SSTR PET probes for neuroendocrine tumor (NET) imaging. The results showed that [18F]AlF-NOTA-JR11 had higher cell binding, but similar pharmacokinetics and tumor uptake compared to [18F]AlF-NOTA-octreotide. Rating: 6/10

NUCLEAR MEDICINE AND BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Experimental and computational studies of tautomerism pyridine carbonyl thiosemicarbazide derivatives

Pawel Kozyra, Agnieszka Kaczor, Zbigniew Karczmarzyk, Waldemar Wysocki, Monika Pitucha

Summary: Tautomerism of 1-(2-, 3- and 4-pyridinecarbonyl)-4-substituted thiosemicarbazide derivatives was studied using NMR spectroscopy, IR, X-ray analysis, and quantum-chemical calculations. The tautomer with both carbonyl and thione groups was found to be the most stable, and the computational results were consistent with experimental data and crystalline forms. These findings enhance our understanding of the structural studies of thiosemicarbazide scaffold and its interaction with potential molecular targets.

STRUCTURAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics

Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille

Summary: In this study, 3p-C-NETA-ePSMA-16 was synthesized and showed high affinity to PSMA, as well as specific uptake in PSMA expressing cells and tumors. It also exhibited improved tumor visualization and imaging contrast compared to other radiopharmaceuticals. Furthermore, 3p-C-NETA-ePSMA-16 has potential for radiotherapy.

PHARMACEUTICALS (2023)

Article Biochemistry & Molecular Biology

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice

Dorota Nieoczym, Nancy Saana Banono, Katarzyna Stepnik, Agnieszka A. Kaczor, Przemyslaw Szybkowski, Camila Vicencio Esguerra, Wirginia Kukula-Koch, Kinga Gawel

Summary: The study aimed to evaluate the anticonvulsant potential of schisandrin B, a main ingredient of Schisandra chinensis extracts. Schisandrin B showed anticonvulsant activity in zebrafish larva seizure assay but did not affect seizure thresholds in mice. The compound crossed the blood-brain barrier and its activity in zebrafish might be due to its binding to benzodiazepine and/or inhibition of glutamate receptors. However, it also displayed teratogenic properties in zebrafish larvae.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy

Tony S. Etelainen, M. Catarina Silva, Johanna K. Uhari-Vaananen, Francesca De Lorenzo, Maria H. Jantti, Hengjing Cui, Marta Chavero-Pieres, Tommi Kilpelainen, Christina Mechtler, Reinis Svarcbahs, Erin Seppala, Juha R. Savinainen, Elena Puris, Gert Fricker, Mikko Gynther, Ulrika H. Julku, Henri J. Huttunen, Stephen J. Haggarty, Timo T. Myohanen

Summary: The inhibition of prolyl oligopeptidase with KYP-2047 reduces tau aggregation, increases PP2A activity, activates autophagic flux, and helps to clear insoluble tau. This study suggests that inhibition of prolyl oligopeptidase could ameliorate tau-dependent neurodegeneration.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Chemistry, Medicinal

Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter

Dayana Castillo Seoane, Marijke De Saint-Hubert, Stephen Ahenkorah, Clarita Saldarriaga Vargas, Maarten Ooms, Lara Struelens, Michel Koole

Summary: This study proposes a multiple time-point protocol and a single time-point protocol for quantification of actinium-225. After scatter correction, accurate measurement of actinium-225 activity can be achieved, and the redistribution of free bismuth-213 can be studied to evaluate related radiotoxicity effects.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2022)

Meeting Abstract Radiology, Nuclear Medicine & Medical Imaging

Radiochemical and preliminary biological comparison of a 3p-C-NETA-PSMA and a DOTA-GA-PSMA derivative

E. Murce, S. Ahenkorah, S. Beekman, L. van den Brink, S. Dalm, F. Cleeren, Y. Seimbille

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

暂无数据